Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

CAR-BCMA T Cells

The CAR-BCMA T cells (study drug) used in this study are chimeric antigen receptor specifically expressing T cells targeting BCMA.

Trial Locations (23)

100000

Beijing Chaoyang hospital, Beijing

215006

The First Affiliated Hospital Of Soochow University, Suzhou

Unknown

The first affiliated hospital of bengbu medical college, Bengbu

Guangdong Provincial People's Hospital, Guangzhou

Sun Yat-sen University Cancer Centre, Guangzhou

The 2nd People's Hospital of Shenzhen, Shenzhen

Henan Cancer Hospital, Zhengzhou

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

The Third Xiangya Hospital of Central South University, Changsha

Xiangya Hospital Central South University, Changsha

Affiliated Hospital of Nantong University, Nantong

Shengjing Hospital of China Medical University, Shenyang

Qilu Hospital of Shandong University, Jinan

The first Affiliated Hospital, College of medicine, Zhejiang University, Hanzhou

The first Affiliated Hospital of Wenzhou Medical University, Wenzhou

Beijing Boren Hospital, Beijing

Beijing Hospital, Beijing

Peking University People's Hospital, Beijing

Peking University Third Hospital, Beijing

Tongji Hospital of Tongji University, Shanghai

Xinhua Hospital Affiliated To Shanghai Jiaotong University School of Medicine, Shanghai

Tianjin Medical University General Hospital, Tianjin

Henan Provincial People's Hospital, Zhengzhou

Sponsors
All Listed Sponsors
collaborator

Beijing Chao Yang Hospital

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Tianjin Medical University General Hospital

OTHER

collaborator

First Affiliated Hospital of Zhejiang University

OTHER

collaborator

Beijing Hospital

OTHER_GOV

collaborator

Shanghai Tongji Hospital, Tongji University School of Medicine

OTHER

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

Peking University People's Hospital

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Sun Yat-sen University

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

lead

CARsgen Therapeutics Co., Ltd.

INDUSTRY